- NEWS ARCHIVES
-
2008
2007
2006
2005
2004
Sun Pharmaceutical received approval for 100 milligram capsules of the anti-convulsant drug, used to treat seizures related to epilepsy and neurosurgery. It is a generic version of Pfizer Inc.'s Phenytoin extended release.
Generic and branded versions of the drug have annual sales of $170 million, according to industry data.